BACKGROUND: We herein report the usefulness of two types of talc pleurodesis for secondary pneumothorax of elderly patients with persistent air leak who have severe pulmonary emphysema. METHODS: We assessed 17 elderly patients with persistent air leak who received talc pleurodesis for secondary pneumothorax from April 2013 to March 2017. Thoracoscopic talc poudrage (TTP) (n=11) was performed in patients whose general condition was thought to sufficiently stable to tolerate for general anesthesia. Talc slurry pleurodesis (TSP) (n=6) via a chest tube was performed in patients whose general condition was thought to be insufficiently stable to tolerate general anesthesia. RESULTS: The median drainage period after pleurodesis was 6 days in patients who received TTP and 12 days in patients who received TSP. Complications associated with talc pleurodesis included atrial fibrillation (n=1) in the thoracoscopic poudrage group, while the slurry pleurodesis group showed chest pain (n=2), asthmatic attack (n=1), and pneumonia (n=1). All patients who received thoracoscopic poudrage were able to leave the hospital after removal of the chest tube. Five of the six patients who received slurry pleurodesis were able to leave the hospital, but one of them died of acute exacerbation of interstitial pneumonia (IP) on the 45th day after pleurodesis. The success rate was 94% (16/17). There were no cases of recurrence during the observation period. CONCLUSIONS: TTP was deemed likely to be safe and effective for patients able to tolerate general anesthesia. In patients with IP, especially those treated with steroids, the indication of talc pleurodesis should be cautiously considered.
BACKGROUND: We herein report the usefulness of two types of talc pleurodesis for secondary pneumothorax of elderly patients with persistent air leak who have severe pulmonary emphysema. METHODS: We assessed 17 elderly patients with persistent air leak who received talc pleurodesis for secondary pneumothorax from April 2013 to March 2017. Thoracoscopic talc poudrage (TTP) (n=11) was performed in patients whose general condition was thought to sufficiently stable to tolerate for general anesthesia. Talc slurry pleurodesis (TSP) (n=6) via a chest tube was performed in patients whose general condition was thought to be insufficiently stable to tolerate general anesthesia. RESULTS: The median drainage period after pleurodesis was 6 days in patients who received TTP and 12 days in patients who received TSP. Complications associated with talc pleurodesis included atrial fibrillation (n=1) in the thoracoscopic poudrage group, while the slurry pleurodesis group showed chest pain (n=2), asthmatic attack (n=1), and pneumonia (n=1). All patients who received thoracoscopic poudrage were able to leave the hospital after removal of the chest tube. Five of the six patients who received slurry pleurodesis were able to leave the hospital, but one of them died of acute exacerbation of interstitial pneumonia (IP) on the 45th day after pleurodesis. The success rate was 94% (16/17). There were no cases of recurrence during the observation period. CONCLUSIONS: TTP was deemed likely to be safe and effective for patients able to tolerate general anesthesia. In patients with IP, especially those treated with steroids, the indication of talc pleurodesis should be cautiously considered.
Authors: Anne Fraticelli; Andrée Robaglia-Schlupp; Helene Riera; Suzanne Monjanel-Mouterde; Pierre Cau; Philippe Astoul Journal: Chest Date: 2002-11 Impact factor: 9.410
Authors: Lisete R Teixeira; Francisco S Vargas; Milena M P Acencio; Pedro F S Paz; Leila Antonangelo; Marcelo A C Vaz; Evaldo Marchi Journal: Chest Date: 2005-12 Impact factor: 9.410
Authors: Julius P Janssen; Gareth Collier; Phillippe Astoul; Gian Franco Tassi; Marc Noppen; Francisco Rodriguez-Panadero; Robert Loddenkemper; Felix Jf Herth; Stefano Gasparini; Charles H Marquette; Birgit Becke; Marios E Froudarakis; Peter Driesen; Chris T Bolliger; Jean-Marie Tschopp Journal: Lancet Date: 2007-05-05 Impact factor: 79.321
Authors: Nick A Maskell; Y C Gary Lee; Fergus V Gleeson; Emma L Hedley; Gerry Pengelly; Robert J O Davies Journal: Am J Respir Crit Care Med Date: 2004-05-13 Impact factor: 21.405
Authors: Jong Duk Kim; Jae Won Choi; Hyun Oh Park; Chung Eun Lee; In Seok Jang; Jun Young Choi; Dong Hoon Kang; Jae Jun Jung; Jun Ho Yang; Sung Ho Moon; Joung Hun Byun; Sung Hwan Kim; Jong Woo Kim Journal: J Thorac Dis Date: 2020-10 Impact factor: 2.895